Science named Treatment as Prevention as the “scientific breakthrough of the year” for 2011, Time named it the number three scientific breakthrough of the year and Reader’s Digest called it a medical breakthrough for 2012.
Science named Treatment as Prevention as the “scientific breakthrough of the year” for 2011, Time named it the number three scientific breakthrough of the year and Reader’s Digest called it a medical breakthrough for 2012.
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025